This is a fabulous paper comparing VATS versus open lobectomy. The 5 year survival is the same, the hospital stay is 2 days less and the in hospital mortality is slightly lower
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic
August 2, 2014
2014 consensus guidelines on the perioperative evaluation and management of patients undergoing NONCARDIAC surgery.
July 28, 2014
Just a quick one and perhaps one to show patients, but a stark contrast between the best lungs and the worst.
Slightly sensationalist but might be effective for a patient that doesn't think that smoking makes a big difference !!
July 26, 2014
This article presents guidelines on the diagnosis and management of advanced stage lung cancer developed by the ESMO in 2013.
July 26, 2014
This article summarizes consensus guidelines for the diagnosis and management of early stage lung cancer developed by ESMO in 2013.
July 12, 2014
This editorial, authored by a number of presidents/leaders of prominent medical societies, laments a recent position paper of the ESMO espousing medical oncologists as the natural team leaders of multidisciplinary oncologic care. It cautions other cancer specialists not to abandon their roles as advocates for their cancer patients.
June 26, 2014
Although lung cancer is common in the elderly population, little information specific to this population is available to inform healthcare practitioners. The EORTC, in collaboration with the International Society of Geriatric Oncology, released a concensus statement in 2010 on this topic. Since then a number of related studies have been published.
May 23, 2014
Stepped wedged cluster randomized control trial from the World Health Organization comparing outcomes in those who received a Checklist. Implementation of the WHO Surgical Safey Checklist decreased morbidty and hospital length of stay.
May 3, 2014
This systematic review and meta-analysis of individual patient data from 15 RCTs (2385 pts) assessed the utility of preoperative chemotherapy in patients with primarily stages Ib-IIIa NSCLC. Chemotherapy resulted in a 13% reduction in death (HR 0.87, p=0.007), and a 5% survival improvement at 5 years.
May 1, 2014
A panel for the Centers for Medicare and Medicaid determined that annual low-dose CT screening for lung cancer carries too high a risk related to the potential benefits. They expressed concern about high false-positive rates, quality assurance, and gaps in evidence as to how the CT results would be used. Despite the fact that many professional grou